Working together to accelerate biomarker discovery, development, and validation across Europe and the world.
EPND (European Platform for Neurodegenerative Diseases) is working to accelerate biomarker discovery, development, and validation by enabling secure, end-to-end discovery, sharing, and analysis of neurodegenerative disease data and biosamples across Europe and beyond.
Provider of information and technology for researchers and clinicians in neurodegenerative disease research, enabling molecular imaging and biomarker access.
A Europe where harmonised real-world data is used by the healthcare community to more rapidly generate high quality insights that improve outcomes for patients.